|
About Ortho Evra Contraceptive Patch
Maker and General Concern
Maker: Ortho McNeil Pharmaceuticals, a division of Johnson & Johnson
As of September 2006, studies confirmed that increased estrogen levels could be detected in women having used the Ortho Evra Contraceptive Patch which increases the chance for blood clots. Levels were determined to be at 60% more total estrogen in blood stream than when taking oral contraceptives. The increased chances of blood clots can then be associated with a higher rate of strokes and heart attacks. Other serious medical problems could also occur.
|